News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VGTI Florida Aims To Stop Spread Of Chikungunya Virus With Novel Vaccine


8/11/2014 8:53:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--It’s another soaking wet rainy season in South Florida, and with it comes ideal conditions for mosquitos to breed and thrive, but this summer brings fears beyond just a pesky bite with the U.S. arrival of the debilitating mosquito-spread virus, chikungunya. Mosquitos can easily and efficiently transmit this virus to humans causing high fever, severe muscle/joint pain, headache, fatigue and rash. While there is currently no FDA-approved vaccine to prevent the spread of the chikungunya virus, the head of viral immunity research at the Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), a leading non-profit biomedical research institute, has developed a new platform vaccine technology that is expected to provide complete protection against chikungunya virus infection.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES